Browsing Tag

Revive Therapeutics

13 posts
best mushroom penny stocks to watch

Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder

TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…
  • September 2, 2020
  • 4 minute read
best penny stocks news

Revive Therapeutics Announces IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19

TORONTO, Aug. 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…
  • August 31, 2020
  • 6 minute read
penny stocks to buy watch news

Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19

Revive to also explore FDA Expanded Access Program (Compassionate Use) for Bucillamine in COVID-19
  • August 26, 2020
  • 6 minute read
best penny stocks news

Revive Therapeutics to Expand Phase 3 Clinical Trial for Bucillamine in COVID-19 in Asia-Pacific and Canada

TORONTO, Aug. 19, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…
  • August 19, 2020
  • 6 minute read
best penny stocks news

Revive Therapeutics Signs MOU with Attwill Medical Solutions for Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 14, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…
  • August 14, 2020
  • 4 minute read
best penny stocks news

Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics

Developed Prototypes of Orally Dissolvable Thin Film For Psilocybin TORONTO, Aug. 11,…
  • August 11, 2020
  • 4 minute read
penny stocks news

Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 05, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…
  • August 5, 2020
  • 6 minute read
penny stocks to buy watch news

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…
  • July 31, 2020
  • 6 minute read
best penny stocks news

Revive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 Confirmatory Study for Bucillamine in COVID-19

TORONTO, June 30, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…
  • June 30, 2020
  • 6 minute read
best penny stocks news

Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison

TORONTO, June 12, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…
  • June 12, 2020
  • 4 minute read